Sanofi Long-Term Concentrated

CIK: 0001121404 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 6, 2025

Total Value ($000): $165,945 (100.0% shares, 0.0% debt)

Holdings (9)

MGTX MeiraGTx Holdings plc 49.8%

Value ($000) $82,701 Shares 12,197,737 Est. Cost $5.86 Unrealized +14.6%

NVAX Novavax 26.6%

Value ($000) $44,104 Shares 6,880,481 Est. Cost $9.64 Unrealized -14.3%

INBX Inhibrx Biosciences, Inc. 9.8%

Value ($000) $16,199 Shares 1,157,926 Est. Cost $15.23 Unrealized -10.8%

ANAB AnaptysBio 9.2%

Value ($000) $15,279 Shares 821,917 Est. Cost $24.22 Unrealized -31.1%

ELDN Eledon 1.7%

Value ($000) $2,763 Shares 814,980 Est. Cost $3.94 Unrealized +4.4%

— LAVA Therapeutics N.V. 1.5%

Value ($000) $2,438 Shares 1,919,455 Est. Cost $0.95 Unrealized —

— IGM Biosciences 1.0%

Value ($000) $1,655 Shares 1,438,975 Est. Cost $6.11 Unrealized —

— Inozyme, Inc 0.2%

Value ($000) $403 Shares 443,255 Est. Cost $2.77 Unrealized —

QTTB Q32 Bio Inc. 0.2%

Value ($000) $403 Shares 244,083 Est. Cost $31.58 Unrealized -91.5%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
MGTX	MeiraGTx Holdings plc	12,197,737	$82,701	49.8%	$5.86	+14.6%	COM	G59665102
NVAX	Novavax	6,880,481	$44,104	26.6%	$9.64	-14.3%	COM NEW	670002401
INBX	Inhibrx Biosciences, Inc.	1,157,926	$16,199	9.8%	$15.23	-10.8%	COM	45720N103
ANAB	AnaptysBio	821,917	$15,279	9.2%	$24.22	-31.1%	COM	032724106
ELDN	Eledon	814,980	$2,763	1.7%	$3.94	+4.4%	COM	28617K101
—	LAVA Therapeutics N.V.	1,919,455	$2,438	1.5%	$0.95	—	SHS	N51517105
—	IGM Biosciences	1,438,975	$1,655	1.0%	$6.11	—	COM	449585108
—	Inozyme, Inc	443,255	$403	0.2%	$2.77	—	COM	45790W108
QTTB	Q32 Bio Inc.	244,083	$403	0.2%	$31.58	-91.5%	COM	746964105